TUMOR CAVITATION IN PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER UNDERGOING CONCURRENT CHEMORADIOTHERAPY: INCIDENCE AND OUTCOMES

被引：0
|
作者：
Phernambucq, Erik C. [1 ]
Hartemink, Koen J. [2 ]
Smit, Egbert F. [1 ]
Paul, M. A. [2 ]
Postmus, Pieter E. [1 ]
Senan, Suresh [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
concurrent chemoradiotherapy; tumor cavitation; stage III NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S633 / S633
页数：1
相关论文
共 50 条
  • [21] Concurrent Chemoradiotherapy Using Advanced Radiotherapy Technologies for Inoperable Stage III Non-Small-Cell Lung Cancer
    Au, Joseph S. K.
    Chan, S. H.
    Yuen, K. T.
    Lee, F.
    Yeung, R. M. W.
    Yau, C. C.
    Li, Y. C.
    Law, C. K.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S452 - S452
  • [22] Concurrent chemoradiotherapy for stage III Non-small-cell lung cancer in clinical practice: Elders versus young
    Girones Sarrio, R.
    Monroy, J. L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S192 - S192
  • [23] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [24] Gender Difference in Treatment Outcomes in Patients with Stage III Non-small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy
    Sekine, Ikuo
    Sumi, Minako
    Ito, Yoshinori
    Tanai, Chiharu
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Kunitoh, Hideo
    Ohe, Yuichiro
    Tamura, Tomohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (11) : 707 - 712
  • [25] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer REPLY
    Antonia, Scott J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (10): : 990 - 990
  • [26] Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)
    Lazar-Poniatowska, Malgorzata
    Bandura, Artur
    Dziadziuszko, Rafal
    Jassem, Jacek
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (04) : 2018 - 2031
  • [27] Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer
    Bao, Yong
    Peng, Fang
    Zhou, Qi-Chao
    Yu, Zhong-Hua
    Li, Jian-Cheng
    Cheng, Zhi-Bin
    Chen, Long
    Hu, Xiao
    Chen, Yuan-Yuan
    Wang, Jin
    Wang, Yan
    Ma, Hong-Lian
    Xu, Zu-Min
    Lu, Ru-Biao
    Deng, Xiao-Wu
    Chen, Ming
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 161 - 166
  • [28] Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
    Zhou, Meng-Xi
    Fan, Wen-Jie
    Zhang, Ning
    Zhu, Li-Yang
    Wang, Hong-Yan
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [29] Durvalumab Induces Sustained Survival Benefit After Concurrent Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Pujol, Jean-Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1271 - +
  • [30] Uptake and outcomes of adjuvant durvalumab following concurrent chemoradiotherapy in unresected stage 3 non-small-cell lung cancer
    Mason, Holly
    Jain, Pooja
    Sun Fei
    Teo, Mark
    Franks, Kevin
    Clarke, Katy
    LUNG CANCER, 2021, 156 : S41 - S41
12345